The protective effects of sonicated Bordetella bronchiseptica bacterin on the immunosuppression of spleen cells induced by anti-cancer drugs (5-fluorouracil, doxorubicin, and vincristine)
- Author:
You-Jeong LEE
1
;
Hong-Gu JOO
Author Information
- Publication Type:Original Article
- From:Korean Journal of Veterinary Research 2022;62(3):e20-
- CountryRepublic of Korea
- Language:Korean
- Abstract: 5-Fluorouracil, doxorubicin, and vincristine are chemotherapy agents used to treat various cancers, such as breast cancer and lymphoma for decades, and their effects on cancer have been proven. On the other hand, these anti-cancer drugs cause fatal side effects, including immunosuppression. This study investigated whether sonicated Bordetella bronchiseptica bacterin can attenuate the immunosuppression of spleen cells induced by these chemotherapy agents and which subsets of spleen cells were affected. B. bronchiseptica increased the metabolic activity of spleen cells treated with 3 anti-cancer drugs. Cell death analysis using Annexin V/propidium iodide showed that B. bronchiseptica markedly decreased the death of spleen cells. The subsets of spleen cells were analyzed by flow cytometry using a surface marker-specific antibody. B. bronchiseptica increased nitric oxide production in the spleen cells treated with anti-cancer drugs (p < 0.0001). Despite the pharmacological effects of anti-cancer drugs, many patients suffer from the fatal side effects of immunosuppression. This study provides valuable information on how to overcome chemotherapy-induced immunosuppression.
